Vallejo has more than 15 years of public accounting experience and has worked for nearly a decade in a senior management position.
Vallejo holds a bachelor's degree in business administration with an emphasis in accounting from San Diego State University. She is a certified public accountant and a member of the American Institute of Certified Public Accountants.
“Veronica has been an integral part of our team since the inception of OncoSec, and this promotion is well-deserved,” said Punit Dhillon, president and CEO. “Her strategic insights and strong financial acumen will be valuable to the future success and growth of the company.”
OncoSec Medical is a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers.
4690 Executive Dr. Ste., 250
San Diego, CA 92121